Working Out M0 Bipolar Androgen Therapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

August 14, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
Prostate Cancer
Interventions
DRUG

Testosterone Enanthate

Testosterone enanthate is a depot formulation used in Australia typically for androgen replacement in people with confirmed testosterone deficiency.

Trial Locations (9)

2010

RECRUITING

St Vincents Hospital, Darlinghurst

2065

RECRUITING

GenesisCare North Shore, St Leonards

2076

RECRUITING

Sydney Adventist Hospital, Wahroonga

2640

RECRUITING

The Border Cancer Hospital, Albury

3128

RECRUITING

Eastern Health - Box Hill, Box Hill

3144

RECRUITING

Cabrini Health, Malvern

3350

RECRUITING

Grampians Health, Ballarat

4032

RECRUITING

ICON Cancer Centre, Chermside

5000

RECRUITING

Royal Adelaide Hospital, Adelaide

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

collaborator

The George Institute

OTHER

collaborator

HMRI

UNKNOWN

lead

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

OTHER